Toggle light / dark theme

There’s no need to don uncomfortable smartwatches or chest straps to monitor your heart if your comfy shirt can do a better job.

That’s the idea behind “” developed by a Rice University lab, which employed its conductive nanotube thread to weave functionality into regular apparel.

The Brown School of Engineering lab of chemical and biomolecular engineer Matteo Pasquali reported in the American Chemical Society journal Nano Letters that it sewed nanotube fibers into athletic wear to monitor the heart rate and take a continual electrocardiogram (EKG) of the wearer.

Technion scientists have created a wearable motion sensor capable of identifying movements such as bending and twisting. This smart ‘e-skin’ was produced using a highly stretchable electronic material, which essentially forms an electronic skin capable of recognizing the range of movement human joints normally make, with up to half a degree precision.

This breakthrough is the result of collaborative work between researchers from different fields in the Laboratory for Nanomaterial-Based Devices, headed by Professor Hossam Haick from the Technion Wolfson Faculty of Chemical Engineering. It was recently published in Advanced Materials and was featured on the journal’s cover.


This wearable motion sensor, which senses bending and twisting, can be applied in healthcare and manufacturing.

LSU Quantum researchers rearrange photon distribution to create different light sources.

For decades, scholars have believed that the quantum statistical properties of bosons are preserved in plasmonic systems, and therefore will not create different form of light.

This rapidly growing field of research focuses on quantum properties of light and its interaction with matter at the nanoscale level. Stimulated by experimental work in the possibility of preserving nonclassical correlations in light-matter interactions mediated by scattering of photons and plasmons, it has been assumed that similar dynamics underlie the conservation of the quantum fluctuations that define the nature of light sources. The possibility of using nanoscale system to create exotic forms of light could pave the way for next-generation quantum devices. It could also constitute a novel platform for exploring novel quantum phenomena.

Ultrafast electron microscope in Argonne’s Center for Nanoscale Materials. Credit: Argonne National Laboratory.

Ultrafast electron microscope opens up new avenues for the development of sensors and quantum devices.

Everyone who has ever been to the Grand Canyon can relate to having strong feelings from being close to one of nature’s edges. Similarly, scientists at the U.S. Department of Energy’s (DOE) Argonne National Laboratory have discovered that nanoparticles of gold act unusually when close to the edge of a one-atom.

Devices in the submillimetre range – so-called “nano-supercapacitors” – allow the shrinkage of electronic components to tiny dimensions. However, they are difficult to produce and do not usually incorporate biocompatible materials. Corrosive electrolytes, for example, can quickly discharge themselves in the event of defects and contamination.

So-called “biosupercapacitors” (BSCs) offer a solution. These have two outstanding properties: full biocompatibility, which means they can be used in body fluids such as blood, and compensation for self-discharge behaviours through bio-electrochemical reactions. In other words, they can actually benefit from the body’s own reactions. This is because, in addition to typical charge storage reactions of a supercapacitor, redox enzymatic reactions and living cells naturally present in the blood can increase the performance of a device by 40%.

Shrinking these devices down to submillimetre sizes, while maintaining full biocompatibility, has been enormously challenging. Now, scientists have created a prototype that combines both essential properties.

The scientists behind the new device were working within the realm of nano-supercapacitors (nBSC), which are conventional capacitors but scaled down to the sub-millimeter scale. Developing these types of devices is tricky enough, but the researchers sought to make one that could work safely in the human body to power tiny sensors and implants, which requires swapping out problematic materials and corrosive electrolytes for ones that are biocompatible.

These devices are known as biosupercapacitors and the smallest ones developed to date is larger than 3 mm3, but the scientists have made a huge leap forward in terms of how tiny biosupercapacitors can be. The construction starts with a stack of polymeric layers that are sandwiched together with a light-sensitive photo-resist material that acts as the current collector, a separator membrane, and electrodes made from an electrically conductive biocompatible polymer called PEDOT: PSS.

This #COVID19 is quite weird it just keeps evolving. In a weird way it is pushing evolution through our immune system. The only thing I know that is similar is like the flu or a bigger organism like cancer. Based on this information the virus just keeps evolving not dying off. Among the weird stuff it doesn’t effect cats or most animals or plants. Basically we either need a universal vaccine which is still being developed or we may need quantum radar to kill off the virus in our bodies when it comes out either that or foglet armor to not breathe it in like Ironman. I find it is just an odd virus as essentially it evolves so fast past even human beings abilities to fend it off even with suits it seems to spread so fast that it cannot be completely contained. From dogs that sniff it out it seems sorta everywhere. I know minor things like high dosages of vitamin c work with zinc and probiotics which was the first way to battle it when it didn’t become this whole pandemic because oddly enough it wasn’t a big deal in previous years because the 19th version of the virus. I know some things that kill it off are ultra violet and lysol as well as bleach. So it makes me think it is more a bioweapon where the universal vaccine would work. But oddly enough I am uncertain if it really dies off especially if it is airborne. If we can destroy the virus by reprogramming it to be sterile or innert or even for it to just kill itself off with crispr like we have done with mosquitoes to stop malaria. We can easily make new vaccines which is good but nearly every year or so there is an entirely new version. This isn’t new but it sorta is like the flu. But there are some theories that I sorta have where it seems to be near heat sources where it grows. Like my uncle who had the virus which we had him turn off electricity and also do vitamin c probiotics and zinc which did work. He ended up getting an antibody naturally this way. I personally got the vaccine and found that it does work but when the new delta version came out it did the same as the last one it sorta just randomly evolves for some reason even smells similar but oddly enough it still remains even after all the lysol. So to me it seems like a bioweapon that is self evolving which is we could use the mechanism to essentially evolve ourselves taking the components of it. If this was a nanobot swarm I would say it spreads from radio waves or something but this virus keeps spreading in odd ways like even from the sky. Which sorta makes me believe that it is sorta being manipulated maybe by a signal perhaps or it has its own program inside it. It reminds me of a Grey goo nanobot swarm that keeps evolving but the biological virus version. I mean it could actually be an exterrestial virus there was a meteorite that came around then and odd things that followed from the meteorite like dogs attacking people and cats attacking people even huge mountain lions. Which makes me think of a sorta an invasion of something. We need to maybe get the viruses input and output to find what it is going to do next. All and all seems odd because even other viruses don’t evolve or like fly or spread that fast. Ideally we should have cyborg nanobots running through Ironman in avengers endgame but so far our best better is treating it like the flu pumping out a new vaccine each year till we know a universal vaccine like using henreitta lacks immortal unlimited cell division cells like they did with polio. But till then we need to keep watching the virus as seems sorta more than it appears based on its original version.


See allHide authors and affiliations.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

I am pleased to announce that my lead-author review paper has been published in ACS Nano! If you are interested in learning about the convergence of synthetic biology and adenoviral gene therapy, I encourage you to check out my paper.

If you cannot access the full text, I have also posted a local copy at the following link: https://logancollinsblog.files.wordpress.com/2021/08/synthet…s-2021.pdf.

#ACS #ACSNano #SyntheticBiology #GeneTherapy #Biology #Biotech #Science #Biotechnology #Nanotechnology #Adenovirus #Engineering #Virology


Synthetic biology centers on the design and modular assembly of biological parts so as to construct artificial biological systems. Over the past decade, synthetic biology has blossomed into a highly productive field, yielding advances in diverse areas such as neuroscience, cell-based therapies, and chemical manufacturing. Similarly, the field of gene therapy has made enormous strides both in proof-of-concept studies and in the clinical setting. One viral vector of increasing interest for gene therapy is the adenovirus (Ad). A major part of the Ad’s increasing momentum comes from synthetic biology approaches to Ad engineering. Convergence of gene therapy and synthetic biology has enhanced Ad vectors by mitigating Ad toxicity in vivo, providing precise Ad tropisms, and incorporating genetic circuits to make smart therapies which adapt to environmental stimuli. Synthetic biology engineering of Ad vectors may lead to superior gene delivery and editing platforms which could find applications in a wide range of therapeutic contexts.

COVID-19 mRNA vaccines and existing gene therapies, including those built with the CRISPR-Cas9 gene-editing tool, are delivered into cells with viral vectors or lipid nanoparticles. A research team led by CRISPR pioneer Feng Zhang, Ph.D., of the Broad Institute has developed a new mRNA delivery system that harnesses a human protein.

The system, dubbed SEND, leverages the ability of a human protein called PEG10 to bind to its own mRNA and form a protective capsule around it. In a new study published in Science, Zhang and colleagues engineered PEG10 to take on RNA cargoes of their choice and successfully delivered the system to mouse and human cells.

The findings support SEND as an efficient delivery platform for RNA-based gene therapies that can be repeatedly dosed, the researchers suggested. Because SEND uses a protein that’s produced naturally in the body, it may not trigger immune responses that can render gene therapies ineffective, the team said.